Clinical impact of 18F-FDG PET/CT in the pretreatment evaluation of patients with locally advanced cervical carcinoma

2012 ◽  
Vol 33 (10) ◽  
pp. 1081-1088 ◽  
Author(s):  
Burcu E. Akkas ◽  
Busra B. Demirel ◽  
Gulin U. Vural
2016 ◽  
Vol 119 ◽  
pp. S340-S341
Author(s):  
S. Cima ◽  
A. Galuppi ◽  
P. De laco ◽  
M. Perrone ◽  
S. Fanti ◽  
...  

2014 ◽  
Vol 69 (12) ◽  
pp. 1235-1243 ◽  
Author(s):  
S. Fleming ◽  
R.A. Cooper ◽  
S.E. Swift ◽  
H.H. Thygesen ◽  
F.U. Chowdhury ◽  
...  

2019 ◽  
Vol 133 ◽  
pp. S806
Author(s):  
S. Cordoba Largo ◽  
V. Garcia Jarabo ◽  
D. Martinez ◽  
M. Ramirez ◽  
M. Gaztañaga Boronat ◽  
...  

2021 ◽  
Vol 2021 ◽  
pp. 1-11
Author(s):  
Sharareh Sanei Sistani ◽  
Fateme Parooie ◽  
Morteza Salarzaei

Objective. The aim of this meta-analysis was to compare the diagnostic accuracy of 18F-FDG-PET/CT and MRI in predicting the tumor response in locally advanced cervical carcinoma (LACC) treated by chemoradiotherapy (CRT). Method. This meta-analysis has been performed according to PRISMA guidelines. Systematic searches were conducted using PubMed and Embase databases for articles published from January 1, 2010, to January 1, 2020. By using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool, the reviewers assessed the methodological quality scores of the selected studies. We analyzed the sensitivity, specificity, and accuracy of two diagnostic methods using Meta-DiSc 1.4 and Stata 15. Results. An overall of 15 studies including 1132 patients were included. Sensitivities of PET/CT and MRI were 83.5% and 82.7%, while the corresponding rates for specificities were 77.8% and 68.4%, respectively. The DOR, PLR, and NLR for MRI were 15.140, 2.92, and 22.6. PET/CT had a DOR of 25.21. The PLR and NLR for PET/CT were 4.13 and 0.215, respectively. The diagnostic sensitivity and specificity of PET/CT for the detection of residual tumor were 86% and 95%, respectively. The corresponding rates for MRI were 73% and 96%, respectively. The diagnostic sensitivity and specificity of PET/CT for the detection of tumor metastases were 97% and 99%, while the corresponding rates for MRI were 31% and 98%, respectively. Conclusion. 18F-FDG PET/CT seemed to have a better overall diagnostic accuracy in the evaluation of treatment response to chemoradiotherapy in LACC patients. MRI showed a really poor sensitivity in the detection of metastases, and PET/CT performed significantly better. However, the difference between these two methods in the detection of residual disease was not significant. More studies are needed to be conducted in order to approve that 18F-FDG PET/CT can be a standard option to assess the treatment response.


2021 ◽  
Vol 161 ◽  
pp. S647
Author(s):  
G. Vullo ◽  
V. De Sanctis ◽  
D. Anzellini ◽  
G. Facondo ◽  
R.C. Sigillo ◽  
...  

2017 ◽  
Vol 42 (1) ◽  
pp. 54-55 ◽  
Author(s):  
Yu-Yu Lu ◽  
Chien-Hsing Lu ◽  
Hsin-Yi Wang

Sign in / Sign up

Export Citation Format

Share Document